Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
90.35
+0.24 (0.27%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Axsome Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Oct '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
4,3373,7663,3491,4243,0423,805
Upgrade
Market Cap Growth
22.11%12.44%135.22%-53.20%-20.03%4425.27%
Upgrade
Enterprise Value
4,2133,5353,2161,3592,8883,781
Upgrade
Last Close Price
90.3579.5977.1337.7881.47103.36
Upgrade
PE Ratio
--15.10-16.76-10.89-29.46-51.45
Upgrade
PS Ratio
14.6813.9266.94---
Upgrade
PB Ratio
41.9919.7230.5791.1026.7421.29
Upgrade
P/FCF Ratio
-22.76-25.86-28.58-13.12-38.76-82.01
Upgrade
P/OCF Ratio
-22.83-25.96-28.75-13.16-38.78-82.04
Upgrade
EV/Sales Ratio
14.4513.0664.28---
Upgrade
EV/EBITDA Ratio
-14.08-19.38-18.36-10.91-29.15-56.37
Upgrade
EV/EBIT Ratio
-14.05-19.33-18.34-10.90-29.15-56.34
Upgrade
EV/FCF Ratio
-21.91-24.27-27.44-12.53-36.79-81.50
Upgrade
Debt / Equity Ratio
1.860.980.863.180.440.11
Upgrade
Debt / FCF Ratio
-1.14-1.28-0.81-0.46-0.64-0.43
Upgrade
Asset Turnover
0.500.590.24---
Upgrade
Inventory Turnover
2.312.68----
Upgrade
Quick Ratio
2.343.462.473.757.858.98
Upgrade
Current Ratio
2.483.632.543.757.859.00
Upgrade
Return on Equity (ROE)
-161.69%-159.21%-298.97%-201.51%-70.36%-76.08%
Upgrade
Return on Assets (ROA)
-28.23%-24.86%-52.29%-56.91%-30.46%-35.55%
Upgrade
Return on Capital (ROIC)
-43.19%-39.31%-81.33%-68.00%-34.16%-40.62%
Upgrade
Earnings Yield
-7.11%-6.35%-5.59%-9.16%-3.38%-1.80%
Upgrade
FCF Yield
-3.87%-3.87%-3.50%-7.62%-2.58%-1.22%
Upgrade
Buyback Yield / Dilution
-9.90%-11.73%-8.07%-1.11%-9.37%-26.55%
Upgrade
Total Shareholder Return
-9.90%-11.73%-8.07%-1.11%-9.37%-26.55%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.